Showing results (1541-1550 of 1,565) with videos related to

Sort By:
Pageof 157
EMBO Molecular Medicine|May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Nature Communications|June 3, 2020
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patientsChek Meng Poh, Guillaume Carissimo, Bei Wang, et al.
Biorxiv : the Preprint Server for Biology|July 24, 2020
Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralizationBei Wang, Daniel Asarnow, Wen-Hsin Lee, et al.
Cell Reports. Medicine|January 26, 2021
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672Michael G Yang, Zili Xiao, Robert J Cherney, et al.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Frontiers in Immunology|December 1, 2022
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individualsYun Shan Goh, Angeline Rouers, Siew-Wai Fong, et al.
Cell Reports|December 8, 2022
Cancer cell-derived type I interferons instruct tumor monocyte polarizationDylan Kwart, Jing He, Subhashini Srivatsan, et al.
ACS Medicinal Chemistry Letters|February 14, 2024
Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncologyYam B Poudel, Liqi He, Matthew Cox, et al.
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
Pageof 157